Teva Pharmaceutical Sets Aside $200 Million for Potential DOJ Settlement - Bloomberg
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges - WSJ
Teva to Pay a $225 Million Settlement for Cholesterol Drug Price-Fixing Charges - news.law
Teva Tops Q2 Earnings Forecast, Holds 2019 Guidance; CFO Departure Hits Shares - TheStreet
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva pharmaceutical industries hi-res stock photography and images - Alamy
Teva makes bid for Mylan
Buyers remorse or fraud? Teva and Mexican brothers slug it out over sour deal
Teva profit plummets, stock slides | Ctech
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Watch CNBC's full interview with Teva CEO Richard Francis - YouTube
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva Pharmaceuticals Q4 2016 Earnings
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Teva Pharma 'uniquely positioned,' Jazz Pharmaceuticals set-up balanced - UBS By Investing.com
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace
What does Teva's growth strategy look like?
Teva boss hits out at opioid lawsuits
Eagle Pharma, Teva Pharma Diverge On 'Surprise' Leukemia Drug Win | Stock News & Stock Market Analysis - IBD
Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
Teva Launches New “Pivot to Growth” Strategy | Business Wire
